810143C

14:0 NBD PE

Avanti Research^™ - A Croda Brand 810143C

• 同義詞: 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt)
• 經驗公式（希爾表示法）: C₃₉H₇₀N₅O₁₁P
• CAS號碼: 474942-82-0
• 分子量：: 815.97
• 分類程式碼代碼: 12352211
• NACRES: NA.25

屬性

• 化驗: >99% (TLC)
• 形狀: liquid
• 包裝: pkg of 1 × 1 mL (810143C-1mg); pkg of 5 × 1 mL (810143C-5mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 810143C
• 濃度: 1 mg/mL (810143C-1mg); 1 mg/mL (810143C-5mg)
• 運輸包裝: dry ice
• 儲存溫度: −20°C

描述

應用

14:0 NBD PE is suitable for the preparation of phospholipid vesicles for lipid mixing assay. It is also suitable to use as fluorescent phospholipid derivative to study the effect of its exchange between β-lactoglobulin (β-LG) and phosphatidylcholine (POPC) bilayers.

生化／生理作用

NBD PE (1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl)) can be used liposome preparation. In which, it might serve as a measure of steady-state fluorescence anisotropy. This might be useful to analyse the mitochondrial membrane structure.

包裝

5 mL Amber Glass Screw Cap Vial (810143C-1mg)

5 mL Amber Glass Screw Cap Vial (810143C-5mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 象形圖: GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• 防範說明: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• 標靶器官: Central nervous system, Liver,Kidney
• 水污染物質分類（WGK）: WGK 3